• 2016 szívünk napja 01
  • 2016 szívünk napja 02
  • 2016 szívünk napja 03
  • 2016 szívünk napja 06
  • 2016 szívünk napja 04
  • 2016 szívünk napja 05
  • 2016 szívünk napja 07
  • 2016 szívünk napja 10
  • 2016 szívünk napja 08
  • 2016 szívünk napja 09
  • 2016 szívünk napja 14
  • 2016 szívünk napja 11
  • 2016 szívünk napja 12
  • 2016 szívünk napja 13
  • 2016 szívünk napja 17
  • 2016 szívünk napja 15
  • 2016 szívünk napja 16
Fighting cardiovascular disease – a blueprint for EU action

In October 2018, the FH Foundation, at its annual Global Summit honored Roger Williams MD to commemorate the twentieth anniversary of publication of the World Health Organization (WHO) Consultation on familial hypercholesterolemia (FH), the most common genetic disorder causing premature atherosclerotic cardiovascular disease, and underscore continued gaps in identification and care. (1) FH, with a prevalence of about 1:220-250 worldwide, causes lifelong elevated levels of low-density lipoprotein cholesterol (LDL-c).

We would like to invite you to participate in the Patient Organisation Advisory Board Meeting concerning Heart Failure (HF) organised by Boehringer Ingelheim RCV GmbH & Co KG, which will be held online due to the current COVID-19 situation.

AIPM has launched a pioneering international initiative which aims to enhance cooperation with patients and patient organizations in the Central and Eastern European region.
The situation caused by the coronavirus requires new solutions.
Downloadable documents

Introduction: The lipid lowering therapy has become one of the basic elements of the cardiovascular prevention and also the attainment of the target levels recommended by the guidelines has an intensified importance in case of patients after acute coronary syndrome (ACS), but it is well known that all over the world this doesn’t reach an acceptable level.

We hope this message finds you well. As promised we would like to officially follow up on our FH Europe Network meeting 2019 in Bucharest. Once again a big thank you to the FOBAC team, speakers and sponsors for their help in organizing this incredible event.

Dear FH Patients!

The following positive information about the domestic support possibility of PCSK9 inhibitors can be shared.